Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Staphylococcus aureus Iron-regulated surface determinant protein B (isdB), partial CSB-YP760614SKV
CSB-EP760614SKV
CSB-BP760614SKV
CSB-MP760614SKV
CSB-EP760614SKV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus UPF0358 protein SAR1086 (SAR1086) CSB-YP760615SKV
CSB-EP760615SKV
CSB-BP760615SKV
CSB-MP760615SKV
CSB-EP760615SKV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Phosphoenolpyruvate-protein phosphotransferase (ptsI), partial CSB-YP760616SKV
CSB-EP760616SKV
CSB-BP760616SKV
CSB-MP760616SKV
CSB-EP760616SKV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Bifunctional protein FolD (folD) CSB-YP760617SKV
CSB-EP760617SKV
CSB-BP760617SKV
CSB-MP760617SKV
CSB-EP760617SKV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Probable quinol oxidase subunit 3 (qoxC), partial CSB-YP760618SKV1
CSB-EP760618SKV1
CSB-BP760618SKV1
CSB-MP760618SKV1
CSB-EP760618SKV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase (menD), partial CSB-YP760619SKV
CSB-EP760619SKV
CSB-BP760619SKV
CSB-MP760619SKV
CSB-EP760619SKV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus UPF0477 protein SAR0985 (SAR0985) CSB-YP760620SKV
CSB-EP760620SKV
CSB-BP760620SKV
CSB-MP760620SKV
CSB-EP760620SKV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Putative O-acetyltransferase SAR0937 (SAR0937), partial CSB-YP760621SKV
CSB-EP760621SKV
CSB-BP760621SKV
CSB-MP760621SKV
CSB-EP760621SKV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Inactive signal peptidase IA (spsA), partial CSB-YP760622SKV
CSB-EP760622SKV
CSB-BP760622SKV
CSB-MP760622SKV
CSB-EP760622SKV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Na (+)/H (+) antiporter subunit D1 (mnhD1), partial CSB-YP760623SKV
CSB-EP760623SKV
CSB-BP760623SKV
CSB-MP760623SKV
CSB-EP760623SKV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus D-alanine--poly (phosphoribitol) ligase subunit 1 (dltA) CSB-YP760624SKV
CSB-EP760624SKV
CSB-BP760624SKV
CSB-MP760624SKV
CSB-EP760624SKV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus UPF0051 protein SAR0880 (SAR0880) CSB-YP760625SKV
CSB-EP760625SKV
CSB-BP760625SKV
CSB-MP760625SKV
CSB-EP760625SKV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Probable protein-export membrane protein SecG (secG), partial CSB-YP760626SKV1
CSB-EP760626SKV1
CSB-BP760626SKV1
CSB-MP760626SKV1
CSB-EP760626SKV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Glyceraldehyde-3-phosphate dehydrogenase 1 (gapA1) CSB-YP760627SKV
CSB-EP760627SKV
CSB-BP760627SKV
CSB-MP760627SKV
CSB-EP760627SKV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Peptidase T (pepT) CSB-YP760628SKV
CSB-EP760628SKV
CSB-BP760628SKV
CSB-MP760628SKV
CSB-EP760628SKV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus HTH-type transcriptional regulator mgrA (mgrA) CSB-YP760629SKV
CSB-EP760629SKV
CSB-BP760629SKV
CSB-MP760629SKV
CSB-EP760629SKV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Response regulator protein graR (graR) CSB-YP760630SKV
CSB-EP760630SKV
CSB-BP760630SKV
CSB-MP760630SKV
CSB-EP760630SKV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Putative antiporter subunit mnhA2 (mnhA2), partial CSB-YP760631SKV
CSB-EP760631SKV
CSB-BP760631SKV
CSB-MP760631SKV
CSB-EP760631SKV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Protein vraX (vraX) CSB-YP760632SKV
CSB-EP760632SKV
CSB-BP760632SKV
CSB-MP760632SKV
CSB-EP760632SKV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Probable branched-chain-amino-acid aminotransferase (ilvE) CSB-YP760633SKV
CSB-EP760633SKV
CSB-BP760633SKV
CSB-MP760633SKV
CSB-EP760633SKV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>